Page 351 - Read Online

Paul J Cancer Metastasis Treat 2020;6:29 I http://dx.doi.org/10.20517/2394-4722.2020.63 Page 29 of 31

150. Das SK, Eder S, Schauer S, Diwoky C, Temmel H, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science
2011;333:233-8.
151. Mantovani G, Maccio A, Mura L, Massa E, Mudu MC, et al. Serum levels of leptin and proinflammatory cytokines in patients with
advanced-stage cancer at different sites. J Mol Med (Berl) 2000;78:554-61.
152. Kir S, White JP, Kleiner S, Kazak L, Cohen P, et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer
cachexia. Nature 2014;513:100-4.
153. Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, et al. A switch from white to brown fat increases energy
expenditure in cancer-associated cachexia. Cell Metab 2014;20:433-47.
154. Tomasin R, Martin A, Cominetti MR. Metastasis and cachexia: alongside in clinics, but not so in animal models. J Cachexia Sarcopenia
Muscle 2019;10:1183-94.
155. Zhang G, Liu Z, Ding H, Zhou Y, Doan HA, et al. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and
Hsp90. Nat Commun 2017;8:589.
156. Lazar I, Clement E, Dauvillier S, Milhas D, Ducoux-Petit M, et al. Adipocyte exosomes promote melanoma aggressiveness through fatty
acid oxidation: a novel mechanism linking obesity and cancer. Cancer Res 2016;76:4051-7.
157. Tomasetti M, Lee W, Santarelli L, Neuzil J. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer
diagnostics and therapy. Exp Mol Med 2017;49:e285.
158. Marinho R, Alcantara PSM, Ottoch JP, Seelaender M. Role of exosomal microRNAs and myomiRs in the development of cancer
cachexia-associated muscle wasting. Front Nutr 2017;4:69.
159. He WA, Calore F, Londhe P, Canella A, Guttridge DC, et al. Microvesicles containing miRNAs promote muscle cell death in cancer
cachexia via TLR7. Proc Natl Acad Sci U S A 2014;111:4525-9.
160. Masri S, Papagiannakopoulos T, Kinouchi K, Liu Y, Cervantes M, et al. Lung adenocarcinoma distally rewires hepatic circadian
homeostasis. Cell 2016;165:896-909.
161. Goncalves MD, Hwang SK, Pauli C, Murphy CJ, Cheng Z, et al. Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc
Natl Acad Sci U S A 2018;115:E743-52.
162. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, et al. Insulin resistance and breast-cancer risk. Int J Cancer
1992;52:511-6.
163. Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, et al. An anti-insulin-like growth factor I receptor antibody that
is a potent inhibitor of cancer cell proliferation. Cancer Res 2003;63:5073-83.
164. Hartl WH, Demmelmair H, Jauch KW, Koletzko B, Schildberg FW. Effect of glucagon on protein synthesis in human rectal cancer in
situ. Ann Surgery 1998;227:390-7.
165. Mayers JR, Torrence ME, Danai LV, Papagiannakopoulos T, Davidson SM, et al. Tissue of origin dictates branched-chain amino acid
metabolism in mutant Kras-driven cancers. Science 2016;353:1161-5.
166. Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, et al. Elevation of circulating branched-chain amino acids is an early event in human
pancreatic adenocarcinoma development. Nat Med 2014;20:1193-8.
167. Bindels LB, Delzenne NM. Muscle wasting: the gut microbiota as a new therapeutic target? Int J Biochem Cell Biol 2013;45:2186-90.
168. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology
2014;146:1525-33.
169. Argiles JM, Lopez-Soriano J, Almendro V, Busquets S, Lopez-Soriano FJ. Cross-talk between skeletal muscle and adipose tissue: a link
with obesity? Med Res Rev 2005;25:49-65.
170. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA. Interleukin-1-induced anorexia in the Rat - influence of prostaglandins.
J Clin Invest 1989;84:228-35.
171. Chauhan A, Sequeria A, Manderson C, Maddocks M, Wasley D, et al. Exploring autonomic nervous system dysfunction in patients with
cancer cachexia: a pilot study. Auton Neurosci 2012;166:93-5.
172. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
173. Murphy KT. The pathogenesis and treatment of cardiac atrophy in cancer cachexia. Am J Physiol Heart Circ Physiol 2016;310:H466-77.
174. Belloum Y, Rannou-Bekono F, Favier FB. Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review).
Oncol Rep 2017;37:2543-52.
175. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51-66.
176. Israel M, Schwartz L. The metabolic advantage of tumor cells. Mol Cancer 2011;10:70.
177. Israël M. A primary cause of cancer: GABA deficiency in endocrine pancreas. Cancer Therapy 2012;8:171-83.
178. Cancer metabolism: an alteration of the anabolic–catabolic selection switch. OA Cancer 2014;2:1.
179. Israël M. Metabolic rewiring of stem cells and differentiated cells in cancer: the hypothetical consequences of a GABA deficiency in
endocrine pancreas. J Cancer Metastasis Treat 2019;5.
180. Kuhn T, Floegel A, Sookthai D, Johnson T, Rolle-Kampczyk U, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to
a lower risk of common cancers in a prospective metabolomics study. BMC Med 2016;14:13.
181. Beleva E, Grudeva-Popova J. From Virchow's triad to metastasis: circulating hemostatic factors as predictors of risk for metastasis in
solid tumors. J BUON 2013;18:25-33.
182. Karikoski M, Marttila-Ichihara F, Elima K, Rantakari P, Hollmen M, et al. Clever-1/stabilin-1 controls cancer growth and metastasis. Clin
Cancer Res 2014;20:6452-64.
183. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients
receiving outpatient chemotherapy. J Thromb Haemost 2007;5:632-4.